Volume 25, Number 12—December 2019
Research
Cost-effectiveness of Prophylactic Zika Virus Vaccine in the Americas
Table
Highest values of VCPI (in 2015 US dollars) for a Zika virus vaccine candidate to be cost-saving, very cost-effective, or cost-effective*
Country | Herd immunity, % | Cost-saving, VCPI | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Very cost-effective |
Cost-effective |
||||||||||
GDP | VCPI | ICER | 95% CI | 3×GDP | VCPI | ICER | 95% CI | ||||
Belize | 21 | $18 | $4,955 | $23 | $3,516 | $144–$4,575 | $14,865 | $34 | $12,092 | $7,379–$15,050 | |
Bolivia | 10 | $22 | $3,097 | $27 | $1,827 | $(872)–$2,669 | $9,291 | $36 | $7,038 | $4,249–$9,745 | |
Brazil | 18 | $14 | $8,694 | $21 | $6,356 | $1,596–$7,223 | $26,082 | $38 | $21,725 | $14,938–$27,441 | |
Colombia | 12 | $16 | $5,900 | $23 | $4,184 | $1,284–$5,349 | $17,700 | $35 | $14,086 | $9,447–$16,736 | |
Costa Rica | 2 | $10 | $11,563 | $16 | $7,352 | $1,280–$9,234 | $34,689 | $29 | $29,061 | $15,459–$30,561 | |
Ecuador | 8 | $24 | $6,084 | $32 | $4,451 | $1,343–$5,560 | $18,252 | $48 | $15,581 | $10,338–$17,576 | |
El Salvador | 16 | $22 | $3,719 | $26 | $1,379 | $(1,884)–$2,826 | $11,157 | $34 | $8,177 | $3,408–$9,785 | |
French Guiana | 18 | $23 | $18,036 | $47 | $14,475 | $10,016–$16,653 | $54,108 | $96 | $49,934 | $36,523–$53,661 | |
Guatemala | 14 | $25 | $4,032 | $32 | $2,544 | $148–$3,944 | $12,096 | $45 | $9,786 | $6,556–$11,859 | |
Guyana | 15 | $18 | $4,325 | $23 | $2,270 | $(285)–$3,717 | $12,975 | $33 | $10,034 | $5,884–$12,262 | |
Honduras | 14 | $21 | $2,358 | $23 | $892 | $(1,711)–$1,705 | $7,074 | $29 | $4,992 | $1,623–$6,142 | |
Mexico | 5 | $17 | $8,867 | $26 | $6,362 | $2,564–$7,445 | $26,601 | $44 | $21,652 | $14,717–$24,875 | |
Nicaragua | 17 | $16 | $2,109 | $18 | $595 | $(1,465)–$1,231 | $6,327 | $24 | $4,829 | $2,395–$6,068 | |
Panama | 15 | $25 | $14,009 | $43 | $11,001 | $7,016–$13,486 | $42,027 | $82 | $37,247 | $29,096–$43,898 | |
Paraguay | 17 | $19 | $4,094 | $23 | $2,348 | $(305)–$3,332 | $12,282 | $32 | $9,903 | $5,028–$10,670 | |
Peru | 4 | $16 | $6,042 | $22 | $4,332 | $1,087–$4,870 | $18,126 | $35 | $14,028 | $9,262 –$16,432 | |
Suriname | 22 | $14 | $7,298 | $21 | $4,434 | $1,505–$6,235 | $21,894 | $37 | $18,705 | $12,714–$22,331 | |
Venezuela | 19 | $21 | $7,766 | $29 | $4,697 | $623–$6,590 | $23,298 | $47 | $19,170 | $13,160–$23,579 |
*Mean ICER values with 95% CI correspond to VCPI values under which the vaccination program is at least 90% cost-effective in each country. The per capita GDP and 3 times the per capita GDP were used as thresholds for very cost-effective and cost-effective analyses, respectively. The dollar values in parentheses indicate that the 95% CI extends to negative ICER values, which is considered cost-saving. GDP, gross domestic product; ICER, incremental cost-effectiveness ratio; VCPI, vaccination cost per individual.